Obluchenie opredelyaet otritsatel'nyy effekt primeneniya granulotsitarnogo koloniestimuliruyushchego faktora posle allogennoy transplantatsii kostnogo mozga

References

[1] Offner F., Schoch G., Fisher L.D. et al. Mortality hazard functions as related to neutropenia at different times after marrow transplantation. Blood 1996; 88(10): 4058-62.

[2] Dekker A., Bulley S., Beyene J. et al. Meta-analysis of randomized controlled trials of prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor after autologous and allogeneic stem cell transplantation. J. Clin. Oncol. 2006; 24(33): 5207-15.

[3] Ringden 0., Labopin M., Gorin N.C. et al. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. J. Clin. Oncol. 2004; 22(3): 416-23.

[4] Ho V.T., Mirza N.Q., Junco D.D. et al. The effect of hematopoietic growth factors on the risk of graft-vs-host disease after allogeneic hematopoietic stem cell transplantation: a meta-analysis. Bone Marrow Transplant. 2003; 32(8): 771-5.

[5] Khoury H.J., Loberiza F.J., Ringdun 0. et al. Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation. Blood 2006; 107(4): 1712-6.

[6] Shlomchik W.D., Couzens M.S., Tang C.B. et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 1999; 285(5426): 412-5.

[7] Morris E.S., MacDonald K.P., Hill G.R. Stem cell mobilization with G-CSF analogs: a rational approach to separate GVHD and GVL? Blood 2006; 107: 3430-5.

RIGHTS & PERMISSIONS

Eco-Vector